AstraZeneca: This vaccine is also being produced by the Serum Institute of India. The vaccine has been seen to be equally effective on people of all ages and communities.
New Delhi. The Corona vaccine of the British-Swedish pharmaceutical company AstraZeneca has once again come under suspicion. The US Health Agency suspects that the company used old data during the trial. Let us know that the day before, AstraZeneca has announced the results of the vaccine trial in America. Under this, it has been said that his vaccine is 79% effective.
According to the US National Institute of Allergy and Infectious Disease, the Data Safety Monitoring Board has raised concerns about AstraZeneca’s data. The board suspects that AstraZeneca used old data during the trial. So it is difficult to tell exactly how effective this vaccine is. The final decision on the use of this vaccine in America will be made by an Advisory Committee.
A large trial of the Oxford AstraZeneca vaccine in 79 percent of US and South American countries has revealed that the vaccine is 79 percent effective at preventing Kovid-19 and up to 100 percent effective at preventing the disease from becoming serious. The third phase of the vaccine, developed by Oxford University and the AstraZeneca Company, was studied in the US, Chile and Peru, confirming its “safe and effective”.
Other countries also had good trial results
before the vaccine was tested in Britain, Brazil and South Africa. This vaccine is also being produced by the Serum Institute of India. The vaccine was seen to be equally effective on people of all ages and communities and it was 80 percent effective on persons above 65 years of age.
Andrew Pollard, a professor at the University of Oxford and the principal investigator of the vaccine, said, “This result is good news because it shows the vaccine’s impact.” It also looks equally effective in the outcome of the Oxford trial. “
